Part D Trends For Five-Tier Formularies, Brand-Drug Coinsurance Rising, Analysis Finds
This article was originally published in The Pink Sheet Daily
Executive Summary
As Part D open enrollment kicked off Oct. 15, a Kaiser Family Foundation found almost 90% of national and near-national plans use five-tier formularies. And more plans are asking patients to shoulder a higher share of brand drug costs through coinsurance rather than a flat copay.
You may also be interested in...
Medicare Part D Plans Expanding Five-Tier Formularies, Preferred Networks In 2013
A review of Part D plan design trends among the leading sponsors shows that Humana has switched to five-tier formularies, UnitedHealth is using a preferred pharmacy network and CVS Caremark is sponsoring plans that include community-based independents in its preferred network.
GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.
Deal Watch: Sanofi, Boehringer Swap Side Businesses
Busy week for AstraZeneca sees buyout of Acerta and acquisition of remaining Daliresp/Daxas worldwide rights from Takeda. Amgen and GSK undo their cancer drug alliances from 2009 and 2010, with all rights reverting to the big biotech.